Corrigendum to ‘Repeated GnRH agonist doses for luteal support: a proof of concept’ (Reproductive BioMedicine Online (2019) 39(5) (770–776), (S1472648319306649), (10.1016/j.rbmo.2019.07.031))

Amir Wiser; Anat Hershko Klement; Tal Shavit; Arie Berkovitz; Roni Rahav Koren; Ofer Gonen; Keren Amichay; Adrian Shulman

doi:10.1016/j.rbmo.2019.12.010

Corrigendum to ‘Repeated GnRH agonist doses for luteal support: a proof of concept’ (Reproductive BioMedicine Online (2019) 39(5) (770–776), (S1472648319306649), (10.1016/j.rbmo.2019.07.031))

Amir Wiser
, Anat Hershko Klement
, Tal Shavit
, Arie Berkovitz
, Roni Rahav Koren
, Ofer Gonen
, Keren Amichay
, Adrian Shulman

Research output: Contribution to journal › Comment/debate

Abstract

The authors regret that the abstract and methods were inconsistent regarding the starting day of luteal support. Both hCG and GnRH agonist were introduced by the 3^rd day post egg retrieval. The corrections should be; 1. In the abstract, ‘Design’ section: ‘: randomized to GnRH agonist luteal support 0.1 mg SC every other day, starting on day 3 after egg retrieval.2. In ‘Materials and Methods’ section: The control group was supported by 80 µg recombinant hCG (Ovitrelle, Merck Serono SA, Bari, Italy). A single dose on day 3 post-egg retrieval.The

Original language	English
Pages (from-to)	343
Number of pages	1
Journal	Reproductive BioMedicine Online
Volume	40
Issue number	2
DOIs	https://doi.org/10.1016/j.rbmo.2019.12.010
State	Published - 1 Feb 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Reproductive Medicine
Obstetrics and Gynecology
Developmental Biology

Access to Document

10.1016/j.rbmo.2019.12.010

Cite this

Wiser, A., Klement, A. H., Shavit, T., Berkovitz, A., Koren, R. R., Gonen, O., Amichay, K., & Shulman, A. (2020). Corrigendum to ‘Repeated GnRH agonist doses for luteal support: a proof of concept’ (Reproductive BioMedicine Online (2019) 39(5) (770–776), (S1472648319306649), (10.1016/j.rbmo.2019.07.031)). Reproductive BioMedicine Online, 40(2), 343. https://doi.org/10.1016/j.rbmo.2019.12.010

@article{6ba9985e0b344bcb814d60db4c9c6b58,

title = "Corrigendum to {\textquoteleft}Repeated GnRH agonist doses for luteal support: a proof of concept{\textquoteright} (Reproductive BioMedicine Online (2019) 39(5) (770–776), (S1472648319306649), (10.1016/j.rbmo.2019.07.031))",

abstract = "The authors regret that the abstract and methods were inconsistent regarding the starting day of luteal support. Both hCG and GnRH agonist were introduced by the 3rd day post egg retrieval. The corrections should be; 1. In the abstract, {\textquoteleft}Design{\textquoteright} section: {\textquoteleft}: randomized to GnRH agonist luteal support 0.1 mg SC every other day, starting on day 3 after egg retrieval.2. In {\textquoteleft}Materials and Methods{\textquoteright} section: The control group was supported by 80 µg recombinant hCG (Ovitrelle, Merck Serono SA, Bari, Italy). A single dose on day 3 post-egg retrieval.The",

author = "Amir Wiser and Klement, \{Anat Hershko\} and Tal Shavit and Arie Berkovitz and Koren, \{Roni Rahav\} and Ofer Gonen and Keren Amichay and Adrian Shulman",

note = "Publisher Copyright: {\textcopyright} 2019 Reproductive Healthcare Ltd.",

year = "2020",

month = feb,

day = "1",

doi = "10.1016/j.rbmo.2019.12.010",

language = "English",

volume = "40",

pages = "343",

journal = "Reproductive BioMedicine Online",

issn = "1472-6483",

publisher = "Elsevier Ltd.",

number = "2",

}

Wiser, A, Klement, AH, Shavit, T, Berkovitz, A, Koren, RR, Gonen, O, Amichay, K & Shulman, A 2020, 'Corrigendum to ‘Repeated GnRH agonist doses for luteal support: a proof of concept’ (Reproductive BioMedicine Online (2019) 39(5) (770–776), (S1472648319306649), (10.1016/j.rbmo.2019.07.031))', Reproductive BioMedicine Online, vol. 40, no. 2, pp. 343. https://doi.org/10.1016/j.rbmo.2019.12.010

Corrigendum to ‘Repeated GnRH agonist doses for luteal support: a proof of concept’ (Reproductive BioMedicine Online (2019) 39(5) (770–776), (S1472648319306649), (10.1016/j.rbmo.2019.07.031)). / Wiser, Amir; Klement, Anat Hershko; Shavit, Tal et al.
In: Reproductive BioMedicine Online, Vol. 40, No. 2, 01.02.2020, p. 343.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to ‘Repeated GnRH agonist doses for luteal support

T2 - a proof of concept’ (Reproductive BioMedicine Online (2019) 39(5) (770–776), (S1472648319306649), (10.1016/j.rbmo.2019.07.031))

AU - Wiser, Amir

AU - Klement, Anat Hershko

AU - Shavit, Tal

AU - Berkovitz, Arie

AU - Koren, Roni Rahav

AU - Gonen, Ofer

AU - Amichay, Keren

AU - Shulman, Adrian

PY - 2020/2/1

Y1 - 2020/2/1

N2 - The authors regret that the abstract and methods were inconsistent regarding the starting day of luteal support. Both hCG and GnRH agonist were introduced by the 3rd day post egg retrieval. The corrections should be; 1. In the abstract, ‘Design’ section: ‘: randomized to GnRH agonist luteal support 0.1 mg SC every other day, starting on day 3 after egg retrieval.2. In ‘Materials and Methods’ section: The control group was supported by 80 µg recombinant hCG (Ovitrelle, Merck Serono SA, Bari, Italy). A single dose on day 3 post-egg retrieval.The

AB - The authors regret that the abstract and methods were inconsistent regarding the starting day of luteal support. Both hCG and GnRH agonist were introduced by the 3rd day post egg retrieval. The corrections should be; 1. In the abstract, ‘Design’ section: ‘: randomized to GnRH agonist luteal support 0.1 mg SC every other day, starting on day 3 after egg retrieval.2. In ‘Materials and Methods’ section: The control group was supported by 80 µg recombinant hCG (Ovitrelle, Merck Serono SA, Bari, Italy). A single dose on day 3 post-egg retrieval.The

UR - https://www.scopus.com/pages/publications/85077711655

U2 - 10.1016/j.rbmo.2019.12.010

DO - 10.1016/j.rbmo.2019.12.010

M3 - Comment/debate

C2 - 31926827

AN - SCOPUS:85077711655

SN - 1472-6483

VL - 40

SP - 343

JO - Reproductive BioMedicine Online

JF - Reproductive BioMedicine Online

IS - 2

ER -

Corrigendum to ‘Repeated GnRH agonist doses for luteal support: a proof of concept’ (Reproductive BioMedicine Online (2019) 39(5) (770–776), (S1472648319306649), (10.1016/j.rbmo.2019.07.031))

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this